XML 16 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Income - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]      
Net Sales (Note 1) [1] $ 1,869,750,000 $ 1,858,745,000 $ 1,993,857,000
Cost of Sales 1,486,137,000 1,519,031,000 1,654,508,000
Gross Profit 383,613,000 339,714,000 339,349,000
Operating Expenses:      
Selling (Note 1) 55,543,000 56,956,000 56,319,000
Administrative (Note 1) 87,362,000 82,577,000 79,243,000
Research, development and technical services (Note 1) 57,986,000 55,037,000 54,263,000
Deferred compensation expense (income) 9,988,000 15,140,000 (2,329,000)
Total Operating expenses 210,879,000 209,710,000 187,496,000
Business restructuring expenses (Note 22) [2] (1,212,000) (2,744,000) (2,588,000)
Operating Income 171,522,000 127,260,000 149,265,000
Other Income (Expense):      
Interest, net (Note 6) (5,409,000) (5,932,000) (10,771,000)
Other, net (Note 8) 4,954,000 4,571,000 (725,000)
Nonoperating Income (Expense), Total (455,000) (1,361,000) (11,496,000)
Income Before Provision for Income Taxes 171,067,000 125,899,000 137,769,000
Provision for Income Taxes (Note 9) 43,411,000 22,798,000 26,664,000
Net Income 127,656,000 103,101,000 111,105,000
Net (Gain) Loss Attributable to Noncontrolling Interest (Note 1) (886,000) 28,000 12,000
Net Income Attributable to Stepan Company $ 126,770,000 $ 103,129,000 $ 111,117,000
Net Income Per Common Share Attributable to Stepan Company (Note 18):      
Basic $ 5.52 $ 4.47 $ 4.83
Diluted $ 5.45 $ 4.42 $ 4.76
Shares Used to Compute Net Income Per Common Share Attributable to Stepan Company (Note 18):      
Basic 22,949 23,054 23,022
Diluted 23,256 23,316 23,325
[1] Net sales are attributed to countries based on the location of the Company facility making the sales.
[2] See Note 22 regarding business restructuring costs.